Stock listing

Hvivo Plc

Selected listing: HVO · LSE · GBX · GB

Hvivo Plc (LSE:HVO), Commercial Services. Latest release Sep 15, 2026: Chief Financial Officer Succession.

HVO:LSEGBXGBUpdated October 2, 2026

Ticker: LSE:HVO
Asset type: Stock
Sector: Commercial Services
Industry: Miscellaneous Commercial Services
Exchange: LSE
Currency: GBX

About Hvivo Plc

The company specializes in the development and commercialization of innovative solutions for infectious diseases. Hvivo focuses on advancing its proprietary technologies and conducting clinical trials to support its product pipeline.

Latest news from Hvivo Plc

Chief Financial Officer Succession

September 15, 2026

HVIVO acquires CRS Berlin, expanding expertise into dermatology and women's health markets

August 27, 2026

hVIVO acquires CRS Berlin, expanding expertise into dermatology and women's health markets

August 27, 2026

HVIVO : H1 2026 Trading Update

July 23, 2026

Change of Auditor

July 13, 2026

All Hvivo Plc news →

Events

Replays

HVIVO PLC (HVO) — Interim results for the six months ended 30 June 2026
Tue, Sep 15, 2026 · 12:30 PM ET
Watch
hVIVO plc (HVO) Q4 2025 Earnings Call
Wed, Apr 15, 2026 · 01:00 PM ET
Watch
HVIVO PLC (HVO) — FY25 Trading Update
Thu, Jan 29, 2026 · 01:00 PM ET
Watch